Glaucoma damages the optic nerve silently, often well before vision loss is noticeable. By the time peripheral vision narrows, the disease has usually progressed. Glaucoma surgery is recommended when eye drops, oral medications, and laser treatments cannot keep intraocular pressure (IOP) low enough to halt that damage. The good news: surgical options have multiplied over the past decade, with minimally invasive techniques (MIGS) joining traditional filtering surgeries to give patients more choices and gentler recoveries.
What Glaucoma Surgery Is and Who Needs It
Glaucoma is a group of eye diseases in which fluid drainage inside the eye is impaired, raising pressure on the optic nerve. The National Eye Institute estimates more than three million Americans have glaucoma, and half are undiagnosed. Open-angle glaucoma is the most common type and is typically painless. Angle-closure glaucoma can be acute and is a true emergency.
Surgery becomes an option when maximally tolerated medications and laser trabeculoplasty fail to reach the target pressure, when adherence to drops is impossible, when side effects are intolerable, or when the optic nerve continues to deteriorate despite seemingly adequate pressure. Acute angle-closure attacks usually require urgent laser peripheral iridotomy followed by definitive treatment.
Types of Glaucoma Surgery
Three broad categories dominate care.
Minimally Invasive Glaucoma Surgery (MIGS)
MIGS includes trabecular micro-bypass stents (iStent, Hydrus), goniotomy procedures (Kahook Dual Blade, Trabectome), and canaloplasty. Most are paired with cataract surgery and use the same micro-incision. Recovery is rapid, complication rates are low, and pressure reduction is modest — typically 20–30%. MIGS is best suited to mild-to-moderate open-angle glaucoma. The American Academy of Ophthalmology describes MIGS as a stepping stone before traditional filtering surgery.
Trabeculectomy
Trabeculectomy creates a new drainage channel by removing a tiny piece of tissue under the upper eyelid, allowing fluid to drain into a bleb beneath the conjunctiva. Pressure reduction is substantial — often 50% or more — making this the workhorse for moderate-to-advanced glaucoma. Mitomycin C is often applied to reduce scarring.
Tube Shunts (Glaucoma Drainage Devices)
Tube shunts (Ahmed, Baerveldt, Molteno) implant a silicone tube that drains fluid to a plate sutured to the eye wall. They are durable in eyes with prior failed surgery, neovascular glaucoma, or scarring conjunctiva. The Tube Versus Trabeculectomy (TVT) Study found similar long-term pressure control with fewer late failures using tube shunts.
How the Procedure Is Performed
Most glaucoma surgeries are outpatient under local anesthesia with light sedation, similar to cataract surgery. MIGS adds 5–10 minutes to a cataract case. Trabeculectomy and tube shunts take 45–90 minutes each. The eye is numbed with a peri-bulbar block, monitored throughout, and the surgeon works under an operating microscope. You go home the same day with a protective shield.
Pre-op evaluation includes visual field testing, optical coherence tomography (OCT) of the optic nerve, gonioscopy to inspect the drainage angle, and a review of all eye drops. Some glaucoma drops, especially prostaglandin analogs, are stopped a few days before surgery to reduce inflammation.
Recovery Timeline
MIGS recovery mirrors cataract surgery — most patients return to desk work within a few days and are off restrictions in two weeks. Trabeculectomy and tube shunts require more careful follow-up. Vision is often blurry for two to six weeks. Steroid drops, antibiotic drops, and dilating drops are used for one to three months. Heavy lifting, bending below the waist, eye rubbing, and swimming are restricted for four to six weeks. Many trabeculectomy patients return for office adjustments — laser suture lysis, needling — to fine-tune pressure during the first three months.
Visual recovery to baseline can take six to twelve weeks for filtering surgeries. Glaucoma surgery preserves vision but rarely improves what has already been lost.
Risks, Complications, and Outcomes
Pressure-lowering success at one year ranges from 70–90% depending on procedure type, glaucoma severity, and prior surgery, per Cleveland Clinic data. MIGS has very low complication rates. Trabeculectomy and tube shunts carry higher risks: bleb-related infection (endophthalmitis, lifetime risk 1–2%), hypotony (pressure that drops too low), choroidal hemorrhage, double vision, and cataract acceleration.
When to seek emergency care: Call your eye surgeon immediately or go to the nearest ophthalmology emergency room if you experience sudden vision loss, severe eye pain, increasing redness or pus discharge, halos around lights with nausea, or a hard, painful eye. These can signal infection, very high pressure, or bleeding inside the eye.
Alternatives to Glaucoma Surgery
Most glaucoma is initially treated with eye drops — prostaglandin analogs, beta-blockers, alpha agonists, carbonic anhydrase inhibitors, and rho kinase inhibitors. Selective laser trabeculoplasty (SLT) is often offered as first-line therapy and can be repeated. The LiGHT trial showed SLT achieved comparable pressure control to drops with fewer side effects. Sustained-release implants (bimatoprost intracameral) reduce the burden of daily drops for some patients. If you are also weighing retinal detachment surgery or corneal transplant, planning sequence and surgeon coordination matter.
Cost Considerations
Medicare and most commercial insurance cover medically necessary glaucoma surgery. Without insurance, MIGS combined with cataract surgery typically adds $1,500 to $3,500 to a $3,000–$5,000 cataract case. Trabeculectomy runs $4,000 to $8,000 per eye, and tube shunts $5,000 to $10,000 because of implant costs. Expect ongoing follow-up visits and medication co-pays. Many specialty pharmacies offer discount programs for branded glaucoma drops. The broader conditions reference library and healthcare costs guide walk through how to layer insurance, manufacturer coupons, and FSA dollars for chronic eye care.
Frequently Asked Questions
Will glaucoma surgery improve my vision?
No. The goal is to preserve the vision you currently have by lowering eye pressure and slowing optic nerve damage. Vision lost to glaucoma cannot be restored, which is why many doctors recommend earlier intervention if pressure targets are not being met.
How long do glaucoma surgeries last?
Trabeculectomy success at 5 years is around 70–80% with appropriate use of mitomycin C. Tube shunts have similar 5-year success with fewer late failures. MIGS effects are more modest and may need to be supplemented later.
Can I stop my glaucoma drops after surgery?
Sometimes. Many patients are off all drops at one year after a successful trabeculectomy. MIGS patients usually still need at least one drop. Tube shunt patients vary widely. The honest goal is to need fewer medications, not necessarily zero.
Is glaucoma surgery painful?
The surgery itself is painless under anesthesia. Mild aching, foreign-body sensation, and tearing are common for several days after filtering surgery and usually respond to Tylenol and rest. Severe pain is not normal and should prompt a call to your surgeon.
The Bottom Line
Glaucoma surgery is about preservation, not improvement. Ask your ophthalmologist what your current target pressure is, how close you are to it on maximal medical therapy, which surgical option matches your stage of disease, and what their bleb-related infection or tube exposure rates look like. Modern care offers a layered approach — drops, laser, MIGS, then traditional filtration — and choosing the right step at the right time is the heart of the conversation.